Facetten
Zugriff
Einrichtung
Medientyp
- Text 9
Karte
Erscheinungsjahr
Autor/in
- Spencer, Andrew
- Weisel, Katja 4
- Usmani, Saad Z 3
- Avet-Loiseau, Hervé 2
- Boccadoro, Mario 2
- alle zeigen
Sprache
9 Einträge gefunden
-
Carfilzomib 56 mg/m2 twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparison
- Weisel, Katja
- Nooka, Ajay K
- Terpos, Evangelos
- Spencer, Andrew
- Goldschmidt, Hartmut
- Dirnberger, Franziska
- DeCosta, Lucy
-
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
- Quach, Hang
- Nooka, Ajay
- Samoylova, Olga
- Venner, Christopher P
- Kim, Kihyun
- Facon, Thierry
- Spencer, Andrew
-
Ixazomib-lenalidomide-dexamethasone in routine clinical practice:effectiveness in relapsed/refractory multiple myeloma
- Hájek, Roman
- Minařík, Jiří
- Straub, Jan
- Pour, Luděk
- Jungova, Alexandra
- Berdeja, Jesus G
- Boccadoro, Mario
-
Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR
- Avet-Loiseau, Hervé
- San-Miguel, Jesus
- Casneuf, Tineke
- Iida, Shinsuke
- Lonial, Sagar
- Usmani, Saad Z
- Spencer, Andrew
-
-
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies
- Mateos, Maria-Victoria
- Spencer, Andrew
- Nooka, Ajay K
- Pour, Ludek
- Weisel, Katja
- Cavo, Michele
- Laubach, Jacob P
-
-
How to manage neutropenia in multiple myeloma.
- Palumbo, Antonio
- Bladé, Jon
- Boccadoro, Mario
- Palladino, Carmela
- Davies, Faith
- Dimopoulos, Meletios
- Dmoszynska, Anna
-